Dexanabinol HU211

The cannabinoid analog dexanabinol, which demonstrated protective efficacy in preclinical TBI models,28 has been tested in a phase II clinical trial in severe TBI patients. The new compound entity was found to be safe and showed that patients treated within 6 h tended to have better control of intracranial and cerebral perfusion pressures.29 This new compound entity is unique in that it combines antioxidant and weak NMDA receptor antagonist properties along with selected anti-inflammatory properties. However, a recently completed multicenter, multinational, phase III trial has reportedly failed to show neuroprotective efficacy.

How To Win Your War Against Back Pain

How To Win Your War Against Back Pain

Knowing the causes of back pain is winning half the battle against it. The 127-page eBook, How To Win Your War Against Back Pain, explains the various causes of back pain in a simple manner and teaches you the various treatment options available. The book is a great pain reliever in itself. The sensible, practical tips that it presents will surely help you bid good-bye to back pain forever.

Get My Free Ebook


Post a comment